Funder
Fogarty International Center
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Adeyemi, O. A., Nowak, R. G., Marzinke, M., Morgan, D., Sam-Agudu, N., Craddock, J., Zhan, M., Crowell, T. A., Baral, S., Ndembi, N., Adebajo, S., & Charurat, M. E. (2023). Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria. PLoS ONE, 18(3), e0282999. https://doi.org/10.1371/journal.pone.0282999
2. Baral, S. D., Ketende, S., Schwartz, S., Orazulike, I., Ugoh, K., Peel, S. A., Ake, J., Blattner, W., & Charurat, M. (2015). Evaluating respondent-driven sampling as an implementation tool for universal coverage of antiretroviral studies among men who have sex with men living with HIV. Journal of Acquired Immune Deficiency Syndromes, 68, S107–S113. https://doi.org/10.1097/QAI.0000000000000438
3. Battle, J. J., & Bennett, N. D. A. (2007). Striving for place: Lesbian, gay, bisexual, and transgender (LGBT) people. In A companion to African American history (pp. 412–445). Blackwell Publishing Ltd. https://doi.org/10.1002/9780470996720.ch26
4. Beyrer, C., Sullivan, P., Sanchez, J., Baral, S. D., Collins, C., Wirtz, A. L., Altman, D., Trapence, G., & Mayer, K. (2013). The increase in global HIV epidemics in MSM. AIDS, 27(17), 2665–2678. https://doi.org/10.1097/01.aids.0000432449.30239.fe
5. Buchbinder, S. P. (2018). Maximizing the benefits of HIV preexposure prophylaxis. Topics in Antiviral Medicine, 25(4), 138–142. http://www.ncbi.nlm.nih.gov/pubmed/29689539.